BRIEF-GSK publishes long-term organ damage analysis for Benlysta

* New long-term organ damage analysis published for GSK's Benlysta (belimumab)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.